ASN001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASN001, covering 2018-03-07 to 2018-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer [Phase 1]